Are you a professional? Activate your profile

Are you already registered? Access Forgot your password?

Financial advisors
Calculation tools
- Calculates the risk and return of a securities portfolio
- Calculate your supplementary pension
News from the UK Stock Exchange

Funds / ETFs / Stock Ranking
Learn about finance
- Financial glossary
- Learning to invest
  The most important concepts of finance
Study Office
- Asset allocation
- Finance app ranking
About us

Financial news - July 2023 - news published 41.122 - readings 747.660

Select company / Select period

Cinemark Holdings Inc.

Statement of Changes in Beneficial Ownership - Form 4

FORM 4 Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 ...

31.07.2023

Transocean Ltd.

TRANSOCEAN LTD. REPORTS SECOND QUARTER 2023 RESULTS - Form 8-K

TRANSOCEAN LTD. REPORTS SECOND QUARTER 2023 RESULTS ● Total contract drilling revenues were $729 million, compared to $649 million in the first quarter of 2023 (total adjusted contract drilling revenues of $748 million, compared to $667 million in the first quarter of 2023); ● Revenue efficiency (1) was 97.2%, compared to 97.8% in the prior quarter; ● Operating and maint ...

31.07.2023

The Goldman Sachs Group Inc.

Primary Offering Prospectus - Form 424B2

Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-269296 The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. Subject to Completion. Dated July 31, 2023. G ...

31.07.2023

The Goldman Sachs Group Inc.

Primary Offering Prospectus - Form 424B2

Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-269296 GS Finance Corp. $1,989,000 Callable Contingent Coupon Equity-Linked Notes due 2025 guaranteed by The Goldman Sachs Group, Inc. The notes do not pay a fixed coupon and may pay no coupon on a payment date. The amount that you will be paid on your notes is based on the performance of the common stock of Freep ...

31.07.2023

Orange County Bancorp Inc.

Statement of Changes in Beneficial Ownership - Form 4

31.07.2023

Arconic Corporation

Quarterly Report for Quarter Ending June 30, 2023 (Form 10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-39162 ARCONIC CORPORATION (E ...

31.07.2023

United Fire Group Inc.

United Fire Group, Inc. Reports Estimates for Second Quarter 2023 Results - Form 8-K

United Fire Group, Inc. Reports Estimates for Second Quarter 2023 Results CEDAR RAPIDS, Iowa, July 31, 2023 (GLOBE NEWSWIRE) - United Fire Group, Inc. (the "Company" or "UFG") (Nasdaq: UFCS) announced today preliminary earnings estimates for the second quarter 2023 results, including net loss of $2.23 per diluted share, and an adjusted operating loss of $2. ...

31.07.2023

Medavail Holdings Inc.

MedAvail Announces 1-for-50 Reverse Stock Split - Form 8-K

MedAvail Announces 1-for-50 Reverse Stock Split PHOENIX, Ariz., July 31, 2023 /GlobeNewswire/ - MedAvail Holdings, Inc. (Nasdaq: MDVL) ("MedAvail" or the "Company"), an innovative pharmacy technology company, announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-50. The reverse stock split will be ...

31.07.2023

Portage Biotech Inc.

Annual Report for Fiscal Year Ending March 31, 2023 (Form 20-F)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31 , 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE ...

31.07.2023

Tarsus Pharmaceuticals Inc.

Supplemental Prospectus - Form 424B5

Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-260665 The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed. A registration statement relating to the securities has become effective under the Securities Act of 1933, as amended. This preliminary prospectus supplement and the accompan ...

31.07.2023

Adamis Pharmaceuticals Corporation

Acquisition/Asset Disposal - Form 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K ___________________________________________ CURRENT REPORT ___________________________________________ PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 25, 2023 ___________________________________________ ADAMIS PHARMACEU ...

31.07.2023

Brown-Forman Corporation

Statement of Changes in Beneficial Ownership - Form 4

31.07.2023

CVR Partners LP

CVR Partners Reports Second Quarter 2023 Resultsand Announces a Cash Distribution of $4.14 - Form 8-K

CVR Partners Reports Second Quarter 2023 Results and Announces a Cash Distribution of $4.14 SUGAR LAND, Texas (July 31, 2023) -CVR Partners, LP ("CVR Partners" or the "Partnership") (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate ("UAN") solution fertilizer products, today announced net income of $60 million, or $5.66 per common u ...

31.07.2023

BMO - Bank of Montreal

Primary Offering Prospectus - Form 424B2

Registration Statement No. 333-264388 Filed Pursuant to Rule 424(b)(2) Pricing Supplement dated July 27, 2023 to the Prospectus Supplement and Prospectus, each dated May 26, 2022 US$3,000,000 Senior Medium-Term Notes, Series I Redeemable Fixed Coupon Notes, Due July 31, 2028 Issuer: Bank of Montreal Title of Notes: Redeemable Fixed Coupon Notes, due July 31, 2028 (the "No ...

31.07.2023

BMO - Bank of Montreal

Primary Offering Prospectus - Form 424B2

Registration Statement No. 333-264388 Filed Pursuant to Rule 424(b)(2) Amendment No. 2 dated July 27, 2023 to the Pricing Supplement dated June 21, 2022 to the Product Supplement dated June 21, 2022, the Prospectus dated May 26, 2022 and the Series I Senior Medium-Term Notes Prospectus Supplement dated May 26, 2022 Issued by Bank of Montreal 800,000 NotesMicroSectors TM Travel ...

31.07.2023

Financial news - July 2023 - news published 41.122 - readings 747.660

Cinemark Holdings Inc.

Statement of Changes in Beneficial Ownership - Form 4

Transocean Ltd.

TRANSOCEAN LTD. REPORTS SECOND QUARTER 2023 RESULTS - Form 8-K

The Goldman Sachs Group Inc.

Primary Offering Prospectus - Form 424B2

The Goldman Sachs Group Inc.

Primary Offering Prospectus - Form 424B2

Orange County Bancorp Inc.

Statement of Changes in Beneficial Ownership - Form 4

Arconic Corporation

Quarterly Report for Quarter Ending June 30, 2023 (Form 10-Q)

United Fire Group Inc.

United Fire Group, Inc. Reports Estimates for Second Quarter 2023 Results - Form 8-K

Medavail Holdings Inc.

MedAvail Announces 1-for-50 Reverse Stock Split - Form 8-K

Portage Biotech Inc.

Annual Report for Fiscal Year Ending March 31, 2023 (Form 20-F)

Tarsus Pharmaceuticals Inc.

Supplemental Prospectus - Form 424B5

Adamis Pharmaceuticals Corporation

Acquisition/Asset Disposal - Form 8-K

Brown-Forman Corporation

Statement of Changes in Beneficial Ownership - Form 4

CVR Partners LP

CVR Partners Reports Second Quarter 2023 Resultsand Announces a Cash Distribution of $4.14 - Form 8-K

BMO - Bank of Montreal

Primary Offering Prospectus - Form 424B2

BMO - Bank of Montreal

Primary Offering Prospectus - Form 424B2

You have reached the maximum number of requests. You can no longer send.

Become Member

€2,99per month

Become Member

€2,99per month

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

Become
Member